Claude Opus 4.7 vs GPT-Rosalind: The AI War is Over🤯
This video covers the latest AI developments including Claude Opus 4.7's major coding improvements, OpenAI's computer-controlling Codex upgrade, and GPT Rosalind for drug discovery. The presenter argues that AI has moved beyond just moving fast to fundamentally changing what's possible across multiple industries.
Summary
The video presents a countdown of the top 10 AI developments from week 43, highlighting significant advances across multiple AI platforms and applications. Claude made two major announcements: Opus 4.7 which can solve 87 out of 100 real software bugs (described as the biggest jump any coding AI has made) and has three times sharper vision, plus Claude Design which allows users to describe prototypes and export to various formats. OpenAI upgraded Codex to control entire computers by opening apps, clicking buttons, and typing, transforming it from a coding tool to a full computer operator. Google launched a Gemini app for Mac and Windows that can read screens and files through a single hotkey. Elon Musk released Grok 4.3 with doubled capacity that can process meeting videos and generate comprehensive business documents. Other notable launches include Canva AI 2.0 for campaign management, Drafted AI for house design (with 86,000 houses already designed), Nvidia Lyra 2.0 for converting images to 3D worlds, VEO 3 integration with YouTube for scene insertion, and most significantly, OpenAI's GPT Rosalind - the first AI built specifically for drug discovery that's already being used by Amgen and Moderna to reduce research timelines from years to months.
Key Insights
- The presenter claims Opus 4.7 solving 87 out of 100 real software bugs represents the biggest jump any coding AI has ever made
- The presenter argues that OpenAI's Codex has transformed from being just a coding tool to an AI that can use your laptop like a human by controlling apps and interfaces
- The presenter states that 86,000 houses have already been designed using Drafted AI, suggesting architects charging five lakhs have gone very quiet
- The presenter claims that GPT Rosalind is the first AI built specifically for drug discovery and is already being used by major companies like Amgen and Moderna
- The presenter concludes that AI isn't just moving fast anymore but is fundamentally changing what's possible across industries
Topics
Full transcript available for MurmurCast members
Sign Up to Access